Brooke Bernhardt, Brenda J. Weigel. "Pediatric-Friendly Formulations: Critical to Maximizing Benefit of Novel Therapeutics Such as Selumetinib for Children With Neurofibromatosis and Other Neoplasms." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco-25-02765